What does jornay PM — cost, amortization mean?

This represents the periodic non-cash expense allocated to the cost of a specific product's intangible assets over their estimated useful life. It is a critical component in understanding the true economic cost of maintaining the product's market exclusivity.

Collegium Pharmaceutical, Inc. COLL Jornay PM — Cost, Amortization

Other product segments

Belbuca

$18.85M0.0%

Symproic and other

$7.29M0.0%

Symproic

$1.82M0.0%

Similar metrics at other companies

JBIJanus North America — Amortization of intangibles

$11.7M+46.3%

SNXAPJ — Intangible Amortization

$834.25K+16.0%

JBIJanus International — Amortization of intangibles

$300K0.0%

WLYBAmortization of product development assets

$4.35M+10.4%

SHCIntangible Amortization

$3.03M-80.2%

WLYBIntangible Amortization

$13.25M+2.7%

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+20.4%

Enterprise value$869.67M+2.5%

P/E15.4×-6.4×

P/S1.5×0.0×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldAmortization.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s jornay pm — cost, amortization.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s jornay PM — cost, amortization?: Collegium Pharmaceutical, Inc. (COLL) reported jornay PM — cost, amortization of $20.96M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s jornay PM — cost, amortization changed year-over-year?: Collegium Pharmaceutical, Inc.'s jornay PM — cost, amortization decreased by 0.0% year-over-year, from $20.96M to $20.96M.
What does jornay PM — cost, amortization mean?: This represents the periodic non-cash expense allocated to the cost of a specific product's intangible assets over their estimated useful life. It is a critical component in understanding the true economic cost of maintaining the product's market exclusivity.